Apogee Therapeutics, Inc.
APGENASDAQHealthcareBiotechnology
As of Sep 2, 2026 close
- Market cap
- $10.19B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $51.80$135.09
- Volume (live)
- -
- Avg. volume (3M)
- 1.51M
APGE was delisted on Oct 24, 2026. Data shown is historical and no longer updated.
Apogee Therapeutics (APGE) Stock Price & Financial Analysis
Apogee Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $135.06 - $135.09 |
|---|---|
| 52-Week High | $135.09 |
| 52-Week Low | $51.80 |
| Open | $135.08 |
| Volume (last close) | 4.95M |
| Average Volume (3M) | 1.51M |
| 50-Day MA | $134.13 |
|---|---|
| 200-Day MA | $91.97 |
| 1-Year Change | +150.97% |
| Market Cap | 10.19B |
|---|---|
| Shares Outstanding | 75.44M |
| Price to Book (P/B) | 8.53 |
| EV/EBITDA | -33.95 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Sep 2, 2026. Data sources and methodology
Apogee Therapeutics at a Glance
As of the Sep 2, 2026 close, Apogee Therapeutics (APGE) has a market capitalization of $10.19B.
As of its latest reported balance sheet, it holds $105.57M in cash and securities against $4.47M of debt, a net cash position of $101.10M.
Apogee Therapeutics does not currently pay a dividend.
The share price is up 151.0% over the past year. At $135.07 (the Sep 2, 2026 close) it sits near the top of its 52-week range of $51.80 to $135.09, above its 200-day moving average of $91.97.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $135.02, 0.00% below the Sep 2, 2026 close.
Frequently Asked Questions About Apogee Therapeutics
What is the current stock price for APGE?
As of the Sep 2, 2026 close, APGE stock trades at $135.07. The 52-week range is $51.80–$135.09, with a day range of $135.06–$135.09.
What is the P/E ratio for APGE?
The P/E ratio (Price-to-Earnings) for APGE is shown in the Key Statistics section. This valuation metric helps compare Apogee Therapeutics, Inc. to industry peers.
Does APGE pay dividends?
Apogee Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for APGE?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for APGE is Hold. The average 12-month price target is $135.02, a 0.0% downside from the Sep 2, 2026 close of $135.07.
What is the market cap of APGE?
As of the Sep 2, 2026 close, Apogee Therapeutics's market capitalization is $10.19B, classifying it as a large-cap company. Apogee Therapeutics operates in the Healthcare sector within the Biotechnology industry.